KurmaPartners retweeted
Say hello to this year's #BIOEurope #StartupSlam judges 👋 @GA_Tech @tvmcapital @JNJInnovation @KurmaPartners @Nicothing Moderated by: @joachimeeckhout of @Labiotech_eu and @MadelaineH0lden
See the full program now >> spr.ly/60171Jy1D @Innovation_F
KurmaPartners retweeted
🌐 #SaclayCrunch
Venez écouter #startups sélectionnées par @PartechShaker & @KurmaPartners le 08/10 aux côtés des 7 grands groupes partenaires @orange @BNPParibas @Groupama @JCDecaux_France @Cisco @econocom @CHANEL
👉 bit.ly/2LJ0ABe
@centralesupelec @Polytechnique
KurmaPartners retweeted
.@KurmaPartners' new Munich office bears 1st fruit, Max Planck spinout Tacalyx, helmed by Shire, Baxalta vet Peter Sondermann @BioCentury's @iBonanos reports: biocentury.com/biocentury/fi…
KurmaPartners retweeted
HTGF: Tacalyx Raises €7m in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment high-tech-gruenderfonds.de/e… @HTGF @Boehringer @KurmaPartners @creathorventure #Tacalyx More German life science business news at [LSG] at life-sciences-germany.com/ne…
KurmaPartners retweeted
🚀Erganeo helps launch start-up Ermium Therapeutics, which has already raised €6.3m in #startup capital : erganeo.com/en/Ermium_raised…
#health #diseases #immunomodulators
@DOMAINTherapeut @KurmaPartners @idinvest
A project @cnrsinnovation @UParisDescartes @Erganeo
@ReseauSATT
KurmaPartners retweeted
Many thanks to all #entrepreneurs at the @idinvest x @KurmaPartners #health #startup dinner on Idinvest's terrace last night!
KurmaPartners retweeted
Very proud to annonce that @yannfleureau has been named as one of the @ForbesUnder30 in Science & Healthcare. #forbes30under30 #innovators #AI #Cardiology forbes.com/sites/michelatind…
KurmaPartners retweeted
Replying to @KurmaPartners
@KurmaPartners is among the most active investor 2017-2018 in Dx
svb.com/trends-insights/repo…
We are happy to announce the launch of our Munich operations headed by newlyappointed Partner Peter Neubeck.
Read the PR here
kurma-partners-website-backe…
#venturecapital #earlystage #biotechnology #germany
KurmaPartners retweeted
Kurma Partners Announces First Closing of
Kurma Biofund III; Targets €150m servier.com/en/communique/ku… @KurmaPartners @servier More French life science business news at [LSE] at Life-Sciences-Europe.com/new…
KurmaPartners retweeted
Spreading good Kurma: How @KurmaPartners is expanding its preseed partnership approach beyond France, rare diseases with its €150 Biofund III buff.ly/2Bi6hzF
KurmaPartners retweeted
We’re pleased to let you know that @UCLIoN is recruiting people with Inclusion Body Myositis (IBM) to take part in the @Orphazyme_AS clinical trial. Find out how you can take part here: qoo.ly/rp58v
KurmaPartners retweeted
.@sensome_ lève 4,6 millions d'euros pour son guide #connecté pour traiter l #AVC. #startup @KurmaPartners @BNPParibas @mindHealthfr
mindhealth.fr/article/12380/…
KurmaPartners retweeted
Delighted to be included in @siliconrepublic's '12 innovative European medtech start-ups to watch'; learn more about how we are naturally restoring the heart valve here: Xeltis.com/technology xitter.cf/siliconrepublic/status…
#Medtech #startups to keep an eye on: @adahealth @AvaWomen @BambiMedical @brainwavebank @Diaceutics @fimmic @HealthBeaconInc @hrtbtmed @Medherant #NeurentMedical @UgenTec @Xeltis #MedtechWeek siliconrepublic.com/start-up…
KurmaPartners retweeted
For the first time, preliminary 1-year data from 3 patients implanted with Xeltis’ restorative pulmonary #heartvalve will be presented at @echsa_assoc by Prof. Tomasz Mroczek’s on June 1. xeltis.com/news #ECHSA2018 #1in100 #RVOT #CHDaware
KurmaPartners retweeted
Xeltis’ restorative heart valves will be in the spotlight at @ICTEHV in Amsterdam on May 18. Professor FJ Schoen, @HarvardMed and CTO @martijncox will provide insights on the technology and on preclinical data. xeltis.com/news #RVOT #ICTEHV #innovation #medtech
KurmaPartners retweeted
“We are proud to be among the last finalists for this high-profile award. This accolade recognizes the potential of our restorative device to make a difference in the lives of children born with congenital heart disease,” said Xeltis CEO @lgrandidier_ xeltis.com/news/
KurmaPartners retweeted
Xeltis has been selected as one of three finalists for the Swiss Medtech Awards. Stay tuned on June 12 to find out the winner; xeltis.com/news #swissmedtechawards #swissmedtechday #innovation
KurmaPartners retweeted
#PitchContest Innovation 5 themes and a jury
buff.ly/2pSdx0g
@AmineMAROUF @KurmaPartners
Theme : Health
#ParisSaclaySpring #SaveTheDate #SmartWeeks #VivaTech #TakeMeToParisSaclay #Innovation
@iledefrance @StartupInfoFr
"
KurmaPartners retweeted
CEO @lgrandidier_ is speaking @MedTechStrat #InnovationDublin2018 today at 3pm as part of the investor panel. Xeltis.com/news Sharing insights from @Xeltis' recent #seriesc round Xeltis.com/news #medtech #innovation Learn about Laurent xeltis.com/wp-content/upload…
























